We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Neurology |

Highlights FREE

JAMA Neurol. 2015;72(9):965. doi:10.1001/jamaneurol.2014.2866.
Text Size: A A A
Published online


Kassardjian and colleagues describe the clinical, serologic, and electrophysiologic characteristics of necrotizing autoimmune myopathy (NAM), compare patient subgroups, and determine clinical outcome predictors. Clinical, electrophysiologic, and pathologic characteristics were collected and compared among patient subgroups, and predictors of response to treatment were identified by univariate logistic regression. They report that NAM was idiopathic in half of this cohort with clinical and histopathologically defined disease and that, in the remainder, NAM was associated with statin medication, cancer, or connective tissue disease. Editorial perspective in support of these data is provided by Matthew N. Meriggioli, MD.

Harrison and colleagues evaluate the clinical relevance of measures of cortical lesion (CL) burden derived from high-field magnetic resonance imaging (MRI) in multiple sclerosis (MS). Lesions were classified as leukocortical, intracortical, or subpial. Images were segmented using the Lesion-TOADS (Topology-Preserving Anatomical Segmentation) algorithm, and brain structure volumes and white matter lesion volume were reported. This study provides in vivo evidence that CLs are associated with cognitive and physical disability in MS and that leukocortical and subpial lesion subtypes have differing clinical relevance. Quantitative assessments of CL burden on high-field MRI may further our understanding of the development of disability and progression in MS and lead to more effective treatments. Editorial perspective in support of these data is provided by Robert T. Naismith, MD.

Willette and coauthors determine whether insulin resistance predicts Alzheimer disease–like global and regional glucose metabolism deficits in late middle–aged participants at risk for Alzheimer disease and examine whether insulin resistance–predicted variation in regional glucose metabolism is associated with worse cognitive performance. Participants underwent cognitive testing, fasting blood draw, and fludeoxyglucose F 18–labeled positron emission tomography at baseline. Their results show that insulin resistance, a prevalent and increasingly common condition in developed countries, is associated with significantly lower regional cerebral glucose metabolism, which in turn may predict worse memory performance.

Gregg et al evaluate the association of incidental cerebral microbleeds (CMBs) with resting-state cerebral blood flow (CBF), cerebral metabolism, cerebrovascular disease, β-amyloid, and cognition. Three-Tesla magnetic resonance imaging was performed with susceptibility-weighted imaging or gradient-recalled echo to assess CMBs, arterial spin labeling for CBF, and T1- and T2-weighted imaging for atrophy, white matter hyperintensities, and infarcts. They find that, in cognitively normal elderly individuals, incidental CMBs in cortical locations are associated with widespread reductions in resting-state CBF, which indicates that chronic hypoperfusion may put these people at risk for neuronal injury and neurodegeneration.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.